Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Vitrolife AB (publ)
  6. Summary
    VITR   SE0011205202

VITROLIFE AB (PUBL)

(VITR)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-09-23 am EDT
201.00 SEK   +5.35%
09/13Swedish Medical Device Group Vitrolife's CEO Steps Down
MT
09/12Vitrolife AB Announces Retirement of Thomas Axelsson as CEO
CI
09/12Vitrolife's CEO to retire
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
09/19/2022 09/20/2022 09/21/2022 09/22/2022 09/23/2022 Date
218.4(c) 214.4(c) 214.6(c) 190.8(c) 201(c) Last
189 091 168 057 86 472 212 087 349 891 Volume
-1.80% -1.83% +0.09% -11.09% +5.35% Change
More quotes
Estimated financial data (e)
Sales 2022 3 232 M 287 M 287 M
Net income 2022 483 M 43,0 M 43,0 M
Net Debt 2022 1 742 M 155 M 155 M
P/E ratio 2022 56,3x
Yield 2022 0,56%
Sales 2023 3 764 M 335 M 335 M
Net income 2023 682 M 60,6 M 60,6 M
Net Debt 2023 1 045 M 92,9 M 92,9 M
P/E ratio 2023 39,9x
Yield 2023 0,69%
Capitalization 27 214 M 2 419 M 2 419 M
EV / Sales 2022 8,96x
EV / Sales 2023 7,51x
Nbr of Employees 1 162
Free-Float 51,7%
More Financials
Company
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for... 
More about the company
Ratings of Vitrolife AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about VITROLIFE AB (PUBL)
09/13Swedish Medical Device Group Vitrolife's CEO Steps Down
MT
09/12Vitrolife AB Announces Retirement of Thomas Axelsson as CEO
CI
09/12Vitrolife's CEO to retire
AQ
07/15TRANSCRIPT : Vitrolife AB, H1 2022 Earnings Call, Jul 15, 2022
CI
07/15INTERIM REPORT Q2, 2022 : Together for successful growth
AQ
07/15Vitrolife AB Reports Earnings Results for the Second Quarter and Six Months Ended June ..
CI
07/05Conference call interim report
AQ
04/29New Interim CFO at BICO
AQ
04/28VITROLIFE AB (PUBL) : Ex-dividend day for final dividend
FA
04/27Report from Annual General Meeting of Vitrolife AB (publ)
AQ
04/27Vitrolife AB Approves Dividend for the Financial Year 2021
CI
04/22TRANSCRIPT : Vitrolife AB, Q1 2022 Earnings Call, Apr 22, 2022
CI
04/22INTERIM REPORT JANUARY-MARCH 2022 : Building on our strong growth momentum
AQ
04/22Vitrolife AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/08Conference call interim report
AQ
More news
News in other languages on VITROLIFE AB (PUBL)
09/13POINT SUR LES FORTES VARIATIONS DU J : Fevertree progresse, KKR n'ira pas plus loin
09/13ACTUALIZACIÓN DE LAS FUERTES VARIACI : Fevertree riendo, Ocado llorando
09/13Le PDG du groupe suédois de dispositifs médicaux Vitrolife quitte ses fonctions
09/12Vitrolife AB (Publ) annonce le départ à la retraite de Thomas Axelsson en tant que PDG
08/29POINT SUR LES FORTES VARIATIONS DU J : Eramet et Engie trinquent
More news
ETFs positioned on VITROLIFE AB (PUBL)ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
IShares OMX Stockholm Capped - SEK0.33%-4.58%Sweden
IShares STOXX Europe Small 200 (DE) - EUR0.31%-6.22%Europe
IShares MSCI Europe Small-Cap ETF - USD0.11%-9.41%Europe
IShares STOXX Europe 600 Health Care (DE) - EUR0.11%-3.70%Europe
IShares MSCI EAFE Small-Cap ETF - USD0.06%-6.16%EAFE
More ETFs positioned on VITROLIFE AB (PUBL)
Chart VITROLIFE AB (PUBL)
Duration : Period :
Vitrolife AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VITROLIFE AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 201,00 SEK
Average target price 405,00 SEK
Spread / Average Target 101%
EPS Revisions
Managers and Directors
Hans Thomas Axelsson Chief Executive Officer
Patrik Tolf Chief Financial Officer
Sigurdur Jón Sigurðsson Chairman
Claus Bisgaard Vice President-Technology
Carlos Antonio Simon Valles Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
VITROLIFE AB (PUBL)-64.11%2 419
ABBOTT LABORATORIES-28.46%176 313
MEDTRONIC PLC-20.10%109 868
BECTON, DICKINSON AND COMPANY-3.49%66 713
HOYA CORPORATION-17.56%35 356
DEXCOM, INC.-39.91%31 666